Related Experiment Video
Updated: Mar 9, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Non-Coding RNAs in Lung Cancer: Contribution of Bioinformatics Analysis to the Development of Non-Invasive Diagnostic
Meik Kunz1, Beat Wolf2,3, Harald Schulze4
1Functional Genomics and Systems Biology Group, Department of Bioinformatics, Biocenter, University of Wuerzburg, 97074 Wuerzburg, Germany. meik.kunz@uni-wuerzburg.de.
Abstract:
Lung cancer is currently the leading cause of cancer related mortality due to late diagnosis and limited treatment intervention. Non-coding RNAs are not translated into proteins and have emerged as fundamental regulators of gene expression. Recent studies reported that microRNAs and long non-coding RNAs are involved in lung cancer development and progression. Moreover, they appear as new promising non-invasive biomarkers for early lung cancer diagnosis. Here, we highlight their potential as biomarker in lung cancer and present how bioinformatics can contribute to the development of non-invasive diagnostic tools. For this, we discuss several bioinformatics algorithms and software tools for a comprehensive understanding and functional characterization of microRNAs and long non-coding RNAs.
Insights
Non-coding RNAs, including microRNAs and long non-coding RNAs, show promise as early lung cancer biomarkers. Bioinformatics tools aid in developing non-invasive diagnostic methods for lung cancer.
Area of Science:
- Biochemistry and Molecular Biology
- Genomics
- Oncology
Background:
- Lung cancer remains a leading cause of cancer mortality, often due to late diagnosis and limited treatment options.
- Non-coding RNAs (ncRNAs) are crucial gene expression regulators, not translated into proteins.
- MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are implicated in lung cancer development and progression.
Approach:
- This review highlights the potential of ncRNAs as non-invasive biomarkers for early lung cancer detection.
- It explores the application of bioinformatics algorithms and software tools for understanding ncRNA function.
- The focus is on developing novel, non-invasive diagnostic tools for lung cancer.
Key Points:
- ncRNAs, specifically miRNAs and lncRNAs, are emerging as promising biomarkers for early lung cancer diagnosis.
- Bioinformatics approaches are essential for comprehensive analysis and functional characterization of these ncRNAs.
- The integration of ncRNA research and bioinformatics can lead to improved non-invasive diagnostic strategies.
Conclusions:
- ncRNAs represent a significant advancement in the search for early lung cancer biomarkers.
- Bioinformatics plays a critical role in unlocking the diagnostic potential of ncRNAs.
- Further research in this area could revolutionize lung cancer diagnostics and patient outcomes.
More Related Videos
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs